Cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled cell proliferation due to genetic mutations in oncogenes and tumor suppressor genes. These mutations lead to the loss of normal cell cycle regulation, allowing cancer cells to divide rapidly and uncontrollably.

• Secondary mechanism: Evasion of apoptosis, where cancer cells avoid programmed cell death. This occurs through alterations in apoptotic pathways, allowing damaged, potentially harmful cells to survive and accumulate.

• Key complication: Metastasis, where cancer cells invade surrounding tissues and spread to distant body sites. This is facilitated by changes in cell adhesion and increased motility, significantly complicating treatment and prognosis.

Patient Profile

Demographics:

52-year-old female, office manager

History:

• Key past medical history: Diagnosed with stage II breast cancer six months ago, hypertension, Type 2 diabetes

• Current medications: Tamoxifen, Metformin, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and shortness of breath

• Key symptoms: Persistent cough, mild chest pain, unintentional weight loss, night sweats

• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 99.5°F, oxygen saturation 91% on room air

Section 1

New Diagnostic Results:

Following the patient's presentation of increasing fatigue, shortness of breath, and other concerning symptoms, further diagnostic tests were ordered to assess potential complications related to her cancer diagnosis. A chest X-ray revealed multiple nodules in both lungs, indicative of possible metastatic spread of her breast cancer. To confirm the suspicion, a CT scan of the chest was performed, which showed multiple bilateral pulmonary nodules and some mediastinal lymphadenopathy, suggesting that the cancer had metastasized to the lungs.

In addition to imaging, laboratory tests were conducted to provide a comprehensive assessment of the patient's current condition. Complete blood count (CBC) results showed mild anemia, with a hemoglobin level of 10.5 g/dL, which could be contributing to her fatigue. Liver function tests indicated elevated levels of alkaline phosphatase and alanine aminotransferase (ALT), raising concerns about possible hepatic involvement or damage. Tumor markers, such as CA 15-3, were also elevated, supporting the diagnosis of metastatic disease.

These findings suggest that the patient's breast cancer has progressed, complicating her treatment plan and necessitating a multidisciplinary approach to manage her symptoms and slow the progression of the disease. The healthcare team must now consider adjusting her therapeutic regimen, potentially incorporating systemic chemotherapy or targeted therapies, and closely monitor her response to these interventions while managing her coexisting conditions of hypertension and diabetes. The new information sets the stage for discussions about the prognosis, treatment goals, and supportive care needs, ensuring the patient receives comprehensive, personalized care.

Section 2

New Complications:

As the patient progressed in her treatment journey, new complications began to emerge, further challenging her clinical management. During a routine follow-up visit, the patient reported a significant increase in her shortness of breath, accompanied by a persistent cough and episodes of hemoptysis. Physical examination revealed diminished breath sounds and crackles in the lower lobes of both lungs, raising concerns about possible pleural effusion or further pulmonary compromise. Vital signs showed a slight fever of 38.2°C (100.8°F), a heart rate of 102 beats per minute, and an oxygen saturation of 88% on room air, indicating hypoxemia and a potential need for supplemental oxygen.

Laboratory investigations were expanded to include arterial blood gases (ABG), which demonstrated a respiratory alkalosis with a pH of 7.48, PaCO2 of 30 mmHg, and PaO2 of 58 mmHg. The patient's D-dimer levels were also elevated, prompting further evaluation for possible pulmonary embolism, a known risk in cancer patients due to hypercoagulability. An urgent CT pulmonary angiogram was ordered, revealing a moderate-sized embolus in the right pulmonary artery, confirming the diagnosis of a pulmonary embolism.

These new findings necessitate immediate intervention and adjustment of the patient's management plan. The healthcare team initiated anticoagulation therapy to address the embolism, while also considering the balance between the risk of bleeding and the need to prevent further thromboembolic events. The patient's oncologist and pulmonologist collaborated to optimize her treatment, addressing both the metastatic spread and the new thrombotic complication. This complex case underscores the importance of vigilant monitoring, prompt recognition of evolving complications, and agile adaptation of treatment strategies to maintain the patient's quality of life and manage her cancer effectively.

Section 3

The patient was admitted to the hospital for closer monitoring and management of her pulmonary embolism. Over the next 48 hours, she was started on low-molecular-weight heparin to manage the thrombotic event. Her oxygen therapy was adjusted to maintain oxygen saturation levels above 92%, and she was closely monitored for any signs of bleeding due to the anticoagulation therapy.

Subsequent assessments revealed a slight improvement in her oxygenation status, with oxygen saturation levels rising to 91% on room air. However, the patient began to complain of new onset pleuritic chest pain and increased fatigue. A repeat chest X-ray was conducted, showing an increase in the size of the pleural effusion, now more pronounced on the left side. This was further confirmed by a follow-up ultrasound, which suggested the effusion was likely exudative, raising concerns about potential infection or tumor-related fluid accumulation.

As the healthcare team deliberated on the next steps, they considered performing a thoracentesis to relieve the patient's symptoms and analyze the pleural fluid for cytology and culture, which could provide insights into any infectious process or malignancy-related changes. This intervention was deemed necessary to guide further treatment decisions. The complexity of the patient's condition underscored the importance of a multidisciplinary approach, with input from oncology, pulmonology, and hematology to balance her cancer treatment with the management of her acute complications. The team aimed to stabilize her condition while continuing to address her underlying cancer, aware that her journey would require ongoing reevaluation and adjustment of therapeutic strategies.

Section 4

As the medical team proceeded with the thoracentesis, the procedure was successful in draining 500 milliliters of straw-colored fluid from the patient's left pleural space. Initial post-procedure assessments indicated a slight improvement in her respiratory status, as her oxygen saturation levels increased to 94% while on room air. However, the patient continued to experience significant fatigue and reported intermittent fevers, prompting further investigation into potential underlying infections or tumor progression.

Laboratory analysis of the pleural fluid revealed a high protein content and an elevated lactate dehydrogenase level, consistent with an exudative effusion. Cytological examination identified malignant cells, suggesting metastasis of her known primary cancer to the pleural space. These findings necessitated a re-evaluation of her current oncological treatment plan, as the presence of malignant pleural effusion indicated disease progression. Concurrently, blood cultures were drawn to rule out any bacterial superinfection, given her fever and recent history of increased fatigue.

The multidisciplinary team met to discuss the implications of these diagnostic results. The oncologists considered adjusting her chemotherapy regimen to better target the metastatic disease, while the pulmonologists recommended ongoing close monitoring of her respiratory status, with potential repeat thoracentesis if the effusion reaccumulated. Hematology continued to oversee the management of her anticoagulation therapy, balancing the risk of thrombotic events with potential bleeding complications. The team recognized the importance of maintaining open communication with the patient and her family, ensuring they were informed and involved in the decision-making process as her treatment plan evolved.

Section 5

As the medical team implemented the adjusted treatment plan, the patient was closely monitored for any changes in her clinical status. Within a week, the patient began to exhibit new symptoms of increased shortness of breath and a persistent cough. A follow-up chest X-ray revealed a reaccumulation of pleural fluid in her left lung, suggesting that the malignant pleural effusion was progressing more rapidly than anticipated. Additionally, the patient’s heart rate had increased to 110 beats per minute, and her respiratory rate was 24 breaths per minute, indicating a possible compensatory response to her respiratory distress. Her blood pressure remained stable at 118/76 mmHg, but her oxygen saturation had dropped to 90% on room air, prompting a switch to supplemental oxygen via nasal cannula.

Laboratory results from the blood cultures returned negative, ruling out bacterial infection as a cause of her fever. However, her complete blood count showed a mild anemia with a hemoglobin level of 9.5 g/dL, which could be contributing to her fatigue and reduced functional capacity. The multidisciplinary team reconvened to discuss these developments, highlighting the need for a more aggressive approach to managing her pleural effusion. Thoracic surgery was consulted for the possibility of a pleurodesis, a procedure that could help prevent further fluid accumulation by inducing adhesion between the pleural layers.

The patient's oncological treatment plan was also reviewed. Given the rapid progression of her metastatic disease, her chemotherapy regimen was adjusted to include a more aggressive combination of agents aimed at slowing the spread of cancer. The team emphasized the importance of ongoing symptom management to improve the patient’s quality of life, including regular pain assessment and nutritional support. The patient's family was engaged in discussions about her prognosis and care preferences, ensuring that any decisions made aligned with her goals and wishes. The multidisciplinary approach remained key in addressing both the immediate and longer-term challenges posed by her complex condition.